» Articles » PMID: 34212254

Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry

Abstract

Background: The liver-first approach in patients with synchronous colorectal liver metastases (CRLM) has gained wide consensus but its role is still to be clarified. We aimed to elucidate the outcome of the liver-first approach and to identify patients who benefit at most from this approach.

Methods: Patients with synchronous CRLM included in the LiverMetSurvey registry between 2000 and 2017 were considered. Three strategies were analyzed, i.e. liver-first approach, colorectal resection followed by liver resection (primary-first), and simultaneous resection, and three groups of patients were analyzed, i.e. solitary metastasis, multiple unilobar CRLM, and multiple bilobar CRLM. In each group, patients from the three strategy groups were matched by propensity score analysis.

Results: Overall, 7360 patients were analyzed: 4415 primary-first, 552 liver-first, and 2393 simultaneous resections. Compared with the other groups, the liver-first group had more rectal tumors (58.0% vs. 31.2%) and higher hepatic tumor burden (more than three CRLMs: 34.8% vs. 24.0%; size > 50 mm: 35.6% vs. 22.8%; p < 0.001). In patients with solitary and multiple unilobar CRLM, survival was similar regardless of treatment strategy, whereas in patients with multiple bilobar metastases, the liver-first approach was an independent positive prognostic factor, both in unmatched patients (3-year survival 65.9% vs. primary-first 60.4%: hazard ratio [HR] 1.321, p = 0.031; vs. simultaneous resections 54.4%: HR 1.624, p < 0.001) and after propensity score matching (vs. primary-first: HR 1.667, p = 0.017; vs. simultaneous resections: HR 2.278, p = 0.003).

Conclusion: In patients with synchronous CRLM, the surgical strategy should be decided according to the hepatic tumor burden. In the presence of multiple bilobar CRLM, the liver-first approach is associated with longer survival than the alternative approaches and should be evaluated as standard.

Citing Articles

Liver-first approach to the treatment of patients with synchronous colorectal liver metastases: a systematic review and meta-analysis.

Bulisani B, Leite M, Waisberg J Einstein (Sao Paulo). 2024; 22:eRW0596.

PMID: 39661858 PMC: 11634356. DOI: 10.31744/einstein_journal/2024RW0596.


RAS mutant transverse colon cancer with multiple liver metastases achieving long-term disease-free survival with postoperative maintenance therapy with aflibercept + FOLFIRI and four repeated radical resections: a case report.

Tanaka Y, Nakanishi R, Sato S, Otake A, Ryujin K, Ikeda S Surg Case Rep. 2024; 10(1):231.

PMID: 39377932 PMC: 11461724. DOI: 10.1186/s40792-024-02033-2.


The Top Ten Annals of Surgical Oncology Original Articles on Twitter/X: 2020-2023.

Jain A, Schultz K, Brainerd M, Murimwa G, Fleming A, Fackche N Ann Surg Oncol. 2024; 31(13):9100-9111.

PMID: 39138773 PMC: 11560640. DOI: 10.1245/s10434-024-15936-z.


Preoperative imaging of colorectal liver metastases: what the radiologist and the multidisciplinary team need to know.

Dempsey P, Farrelly C, Cronin C, Fenlon H Br J Radiol. 2024; 97(1162):1602-1618.

PMID: 39078288 PMC: 11417391. DOI: 10.1093/bjr/tqae133.


Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: a large population-based analysis.

Hou S, Li L, Hou H, Zhou T, Zhou H Discov Oncol. 2024; 15(1):315.

PMID: 39073708 PMC: 11286894. DOI: 10.1007/s12672-024-01182-y.


References
1.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M . Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103:356-387. DOI: 10.1016/j.ejca.2018.07.005. View

2.
Fong Y, Fortner J, Sun R, Brennan M, Blumgart L . Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230(3):309-18; discussion 318-21. PMC: 1420876. DOI: 10.1097/00000658-199909000-00004. View

3.
Simmonds P, Primrose J, Colquitt J, Garden O, Poston G, Rees M . Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006; 94(7):982-99. PMC: 2361241. DOI: 10.1038/sj.bjc.6603033. View

4.
Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L . Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol. 2008; 15(9):2458-64. DOI: 10.1245/s10434-008-9935-9. View

5.
Adam R, De Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E . Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015; 41(9):729-41. DOI: 10.1016/j.ctrv.2015.06.006. View